Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 20 de 64
1.
J Pineal Res ; 71(1): e12747, 2021 Aug.
Article En | MEDLINE | ID: mdl-34085316

Mitochondrial dysfunction is considered one of the hallmarks of ischemia/reperfusion injury. Mitochondria are plastic organelles that undergo continuous biogenesis, fusion, and fission. They can be transferred between cells through tunneling nanotubes (TNTs), dynamic structures that allow the exchange of proteins, soluble molecules, and organelles. Maintaining mitochondrial dynamics is crucial to cell function and survival. The present study aimed to assess the effects of melatonin on mitochondrial dynamics, TNT formation, and mitochondria transfer in HT22 cells exposed to oxygen/glucose deprivation followed by reoxygenation (OGD/R). The results showed that melatonin treatment during the reoxygenation phase reduced mitochondrial reactive oxygen species (ROS) production, improved cell viability, and increased the expression of PGC1α and SIRT3. Melatonin also preserved the expression of the membrane translocase proteins TOM20 and TIM23, and of the matrix protein HSP60, which are involved in mitochondrial biogenesis. Moreover, it promoted mitochondrial fusion and enhanced the expression of MFN2 and OPA1. Remarkably, melatonin also fostered mitochondrial transfer between injured HT22 cells through TNT connections. These results provide new insights into the effect of melatonin on mitochondrial network reshaping and cell survival. Fostering TNTs formation represents a novel mechanism mediating the protective effect of melatonin in ischemia/reperfusion injury.


Brain Ischemia/pathology , Cell Membrane Structures/drug effects , Melatonin/pharmacology , Mitochondria/drug effects , Neurons/ultrastructure , Animals , Cell Line , Hippocampus/drug effects , Hippocampus/pathology , Hippocampus/ultrastructure , Mice , Mitochondria/metabolism , Nanotubes , Neurons/drug effects , Neurons/pathology , Reperfusion Injury/pathology
2.
Pharmacol Res ; 170: 105541, 2021 08.
Article En | MEDLINE | ID: mdl-33711434

Diversiform ways of intercellular communication are vital links in maintaining homeostasis and disseminating physiological states. Among intercellular bridges, tunneling nanotubes (TNTs) discovered in 2004 were recognized as potential pharmacology targets related to the pathogenesis of common or infrequent neurodegenerative disorders. The neurotoxic aggregates in neurodegenerative diseases including scrapie prion protein (PrPSc), mutant tau protein, amyloid-beta (Aß) protein, alpha-synuclein (α-syn) as well as mutant Huntington (mHTT) protein could promote TNT formation via certain physiological mechanisms, in turn, mediating the intercellular transmission of neurotoxicity. In this review, we described in detail the skeleton, the formation, the physicochemical properties, and the functions of TNTs, while paying particular attention to the key role of TNTs in the transport of pathological proteins during neurodegeneration.


Cell Communication , Cell Membrane Structures/metabolism , Nerve Degeneration , Neurodegenerative Diseases/metabolism , Animals , Cell Membrane Structures/drug effects , Cell Membrane Structures/pathology , Humans , Nanotubes , Neurodegenerative Diseases/drug therapy , Neurodegenerative Diseases/pathology , Neuroprotective Agents/therapeutic use , Protein Aggregates , Protein Aggregation, Pathological , Protein Transport
3.
Phys Chem Chem Phys ; 21(36): 20211-20218, 2019 Sep 18.
Article En | MEDLINE | ID: mdl-31486459

In spite of their well-known side effects, the nonsteroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medications for their antipyretic and anti-inflammatory actions. Interaction of NSAIDs with the plasma membrane plays a vital role in their therapeutic actions and defines many of their side effects. In the present study, we investigate the effects of three NSAIDs, aspirin, ibuprofen, and indomethacin, on the structure and dynamics of a model plasma membrane using a combination of small angle neutron scattering (SANS) and neutron spin echo (NSE) techniques. The SANS and NSE measurements were carried out on a 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) membrane, with and without NSAIDs, at two different temperatures, 11 °C and 37 °C, where the DMPC membrane is in the gel and fluid phase, respectively. SANS data analysis shows that incorporation of NSAIDs leads to bilayer thinning of the membrane in both the phases. The dynamic properties of the membrane are represented by the intermediate scattering functions for NSE data, which are successfully described by the Zilman and Granek model. NSE data analysis shows that in both gel and fluid phases, addition of NSAIDs results in a decrease in the bending rigidity and compressibility modulus of the membrane, which is more prominent when the membrane is in the gel phase. The magnitude of the effect of NSAIDs on the bending rigidity and compressibility modulus of the membrane in the gel phase follows an order of ibuprofen > aspirin > indomethacin, whereas in the fluid phase, it is in the order of aspirin > ibuprofen > indomethacin. We find that the interaction between NSAIDs and phospholipid membranes is strongly dependent on the chemical structure of the drugs and physical state of the membrane. Mechanical properties of the membrane can be quantified by the membrane's bending rigidity. Hence, the present study reveals that incorporation of NSAIDs modulates the mechanical properties of the membrane, which may affect several physiological processes, particularly those linked to the membrane curvature.


Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cell Membrane Structures/chemistry , Cell Membrane Structures/drug effects , Cell Membrane/drug effects , Neutrons , Scattering, Small Angle
4.
Neuropharmacology ; 128: 54-62, 2018 Jan.
Article En | MEDLINE | ID: mdl-28947378

The amyloid hypothesis of Alzheimer's disease suggests that synaptic degeneration and pathology is caused by the accumulation of amyloid-ß (Aß) peptides derived from the amyloid precursor protein (APP). Subsequently, soluble Aß oligomers cause the loss of synaptic proteins from neurons, a histopathological feature of Alzheimer's disease that correlates with the degree of dementia. In this study, the production of toxic forms of Aß was examined in vitro using 7PA2 cells stably transfected with human APP. We show that conditioned media from 7PA2 cells containing Aß oligomers caused synapse degeneration as measured by the loss of synaptic proteins, including synaptophysin and cysteine-string protein, from cultured neurons. Critically, conditioned media from 7PA2 cells treated with valproic acid (2-propylpentanoic acid (VPA)) or propylisopropylacetic acid (PIA) did not cause synapse damage. Treatment with VPA or PIA did not significantly affect total Aß42 concentrations; rather these drugs selectively reduced the concentrations of Aß42 oligomers in conditioned media. In contrast, treatment significantly increased the concentrations of Aß42 monomers in conditioned media. VPA or PIA treatment reduced the concentrations of APP within lipid rafts, membrane compartments associated with Aß production. These effects of VPA and PIA were reversed by the addition of platelet-activating factor, a bioactive phospholipid produced following activation of phospholipase A2, an enzyme sensitive to VPA and PIA. Collectively these data suggest that VPA and PIA reduce Aß oligomers through inhibition of phospholipase A2 and suggest a novel therapeutic approach to Alzheimer's treatment.


Amyloid beta-Peptides/metabolism , Enzyme Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Valproic Acid/pharmacology , Amyloid beta-Protein Precursor/genetics , Amyloid beta-Protein Precursor/metabolism , Animals , CHO Cells , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Cells, Cultured , Cerebral Cortex/cytology , Cholesterol/metabolism , Cricetulus , Culture Media, Conditioned/pharmacology , Embryo, Mammalian , Epilepsy, Temporal Lobe , Gene Expression Regulation/genetics , HSP40 Heat-Shock Proteins/metabolism , Humans , Membrane Proteins/metabolism , Neurons/drug effects , Neurons/metabolism , Platelet Activating Factor/pharmacology , Synaptophysin/metabolism , Transfection
5.
Arch Microbiol ; 200(2): 281-289, 2018 Mar.
Article En | MEDLINE | ID: mdl-29075867

The mycolic acid layer and S-layer of Corynebacterium glutamicum have been considered as permeability barriers against lytic agents. EGTA, a calcium chelator, inhibited C. glutamicum growth at relatively lower concentrations compared with other Gram-positive bacteria. We investigated the effect of EGTA on C. glutamicum cell surface structures. Simultaneous addition of EGTA and lysozyme resulted in cell lysis, whereas addition of these reagents separately had no such effect. Analysis of cell surface proteins showed that CspB, an S-layer protein, was released into the culture media and degraded to several sizes upon EGTA treatment. These findings suggest that EGTA treatment causes release and proteolysis of the CspB protein, resulting in increased cell surface permeability. FE-SEM visualization further confirmed alteration of cell surface structures in EGTA-treated cells. This is the first report suggesting the importance of calcium ions in cell surface integrity of C. glutamicum.


Bacterial Proteins/metabolism , Calcium Chelating Agents/pharmacology , Cell Membrane Permeability/drug effects , Cell Membrane Structures/drug effects , Corynebacterium glutamicum/metabolism , Egtazic Acid/pharmacology , Muramidase/pharmacology , Cell Membrane/metabolism , Corynebacterium glutamicum/growth & development , Membrane Glycoproteins/metabolism , Membrane Proteins/metabolism , Mycolic Acids/metabolism
6.
Physiol Rep ; 5(22)2017 Nov.
Article En | MEDLINE | ID: mdl-29150591

Cholesterol is a key component of the cell plasma membrane. It has been suggested that the t-tubule membrane of cardiac ventricular myocytes is enriched in cholesterol and that this plays a role in determining t-tubule structure and function. We have used methyl-ß-cyclodextrin (MßCD) to deplete cholesterol in intact and detubulated mouse ventricular myocytes to investigate the contribution of cholesterol to t-tubule structure, membrane capacitance, and the distribution of Ca flux pathways. Depletion of membrane cholesterol was confirmed using filipin; however, di-8-ANEPPS staining showed no differences in t-tubule structure following MßCD treatment. MßCD treatment had no significant effect on the capacitance:volume relationship of intact myocytes or on the decrease in capacitance:volume caused by detubulation. Similarly, Ca influx and efflux were not altered by MßCD treatment and were reduced by a similar amount following detubulation in untreated and MßCD-treated cells. These data show that cholesterol depletion has similar effects on the surface and t-tubule membranes and suggest that cholesterol plays no acute role in determining t-tubule structure and function.


Calcium Signaling , Cell Membrane Structures/metabolism , Cholesterol/metabolism , Myocytes, Cardiac/metabolism , Animals , Calcium/metabolism , Cell Membrane Structures/drug effects , Cell Membrane Structures/physiology , Cells, Cultured , Heart Ventricles/cytology , Membrane Potentials , Mice , Mice, Inbred C57BL , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/physiology , beta-Cyclodextrins/pharmacology
7.
Article En | MEDLINE | ID: mdl-28607018

Ciprofloxacin, meropenem, fosfomycin, and polymyxin B strongly increase production of outer membrane vesicles (OMVs) in Escherichia coli O104:H4 and O157:H7. Ciprofloxacin also upregulates OMV-associated Shiga toxin 2a, the major virulence factor of these pathogens, whereas the other antibiotics increase OMV production without the toxin. These two effects might worsen the clinical outcome of infections caused by Shiga toxin-producing E. coli Our data support the existing recommendations to avoid antibiotics for treatment of these infections.


Anti-Bacterial Agents/pharmacology , Cell Membrane Structures/drug effects , Escherichia coli O104/drug effects , Escherichia coli O157/drug effects , Shiga Toxin 2/biosynthesis , Ciprofloxacin/pharmacology , Escherichia coli Infections/drug therapy , Escherichia coli O104/pathogenicity , Escherichia coli O157/pathogenicity , Fosfomycin/pharmacology , Hemolytic-Uremic Syndrome/drug therapy , Hemolytic-Uremic Syndrome/microbiology , Humans , Meropenem , Microbial Sensitivity Tests , Polymyxin B/pharmacology , Thienamycins/pharmacology
8.
Neuropharmacology ; 101: 225-36, 2016 Feb.
Article En | MEDLINE | ID: mdl-26432105

Alzheimer's disease is associated with the accumulation within the brain of amyloid-ß (Aß) peptides that damage synapses and affect memory acquisition. This process can be modelled by observing the effects of Aß on synapses in cultured neurons. The addition of picomolar concentrations of soluble Aß derived from brain extracts triggered the loss of synaptic proteins including synaptophysin, synapsin-1 and cysteine string protein from cultured neurons. Glimepiride, a sulphonylurea used for the treatment of diabetes, protected neurons against synapse damage induced by Aß. The protective effects of glimepiride were multi-faceted. Glimepiride treatment was associated with altered synaptic membranes including the loss of specific glycosylphosphatidylinositol (GPI)-anchored proteins including the cellular prion protein (PrP(C)) that acts as a receptor for Aß42, increased synaptic gangliosides and altered cell signalling. More specifically, glimepiride reduced the Aß-induced increase in cholesterol and the Aß-induced activation of cytoplasmic phospholipase A2 (cPLA2) in synapses that occurred within cholesterol-dense membrane rafts. Aß42 binding to glimepiride-treated neurons was not targeted to membrane rafts and less Aß42 accumulated within synapses. These studies indicate that glimepiride modified the membrane micro-environments in which Aß-induced signalling leads to synapse damage. In addition, soluble PrP(C), released from neurons by glimepiride, neutralised Aß-induced synapse damage. Such observations raise the possibility that glimepiride may reduce synapse damage and hence delay the progression of cognitive decline in Alzheimer's disease.


Amyloid beta-Peptides/pharmacology , Immunosuppressive Agents/pharmacology , Neurons/drug effects , Peptide Fragments/pharmacology , Sulfonylurea Compounds/pharmacology , Aged , Alzheimer Disease/pathology , Cell Membrane Structures/drug effects , Cells, Cultured , Cholesterol/metabolism , Enzyme-Linked Immunosorbent Assay , Female , Humans , Phospholipases A2/metabolism , Prions/metabolism , Synaptophysin/metabolism , Synaptosomes/drug effects , Synaptosomes/metabolism , Temporal Lobe/pathology
9.
ACS Nano ; 9(7): 6738-46, 2015 Jul 28.
Article En | MEDLINE | ID: mdl-26057701

A recent finding reports that co-stimulation of the high-affinity immunoglobulin E (IgE) receptor (FcεRI) and the chemokine receptor 1 (CCR1) triggered formation of membrane nanotubes among bone-marrow-derived mast cells. The co-stimulation was attained using corresponding ligands: IgE binding antigen and macrophage inflammatory protein 1α (MIP1 α), respectively. However, this approach failed to trigger formation of nanotubes among rat basophilic leukemia (RBL) cells due to the lack of CCR1 on the cell surface (Int. Immunol. 2010, 22 (2), 113-128). RBL cells are frequently used as a model for mast cells and are best known for antibody-mediated activation via FcεRI. This work reports the successful formation of membrane nanotubes among RBLs using only one stimulus, a hapten of 2,4-dinitrophenyl (DNP) molecules, which are presented as nanostructures with our designed spatial arrangements. This observation underlines the significance of the local presentation of ligands in the context of impacting the cellular signaling cascades. In the case of RBL, certain DNP nanostructures suppress antigen-induced degranulation and facilitate the rearrangement of the cytoskeleton to form nanotubes. These results demonstrate an important scientific concept; engineered nanostructures enable cellular signaling cascades, where current technologies encounter great difficulties. More importantly, nanotechnology offers a new platform to selectively activate and/or inhibit desired cellular signaling cascades.


Basophils/ultrastructure , Cell Membrane Structures/ultrastructure , Haptens/chemistry , Nanostructures/chemistry , Animals , Cell Line, Tumor , Cell Membrane Structures/drug effects , Haptens/pharmacology , Rats
10.
Clin Chim Acta ; 444: 264-70, 2015 Apr 15.
Article En | MEDLINE | ID: mdl-25748035

BACKGROUND: Glucose-6-phosphate dehydrogenase deficiency affects over 400 million people worldwide. The hemolytic anemia in G6PD deficiency is usually triggered by oxidative stress, but the mechanism remains uncertain. We have used atomic force microscopy for studying changes in red blood cell membrane and providing new insights on the mechanism. METHODS: G6PD activity assay and molecular genetic tests were used for molecular diagnosis. AFM was used to investigate alterations in the ultrastructure of G6PD deficient RBC membranes, the influence of different primaquine concentrations, and the protective effects of vitamin C. RESULT: Nine variants were identified from 33 G6PD deficient individuals. AFM imaging and quantitative analysis showed that G6PD deficient erythrocytes became heterogeneous and roughness measurements of erythrocyte membranes are increased. G6PD enzyme activity and different mutations may relate with roughness parameters. Furthermore, primaquine induces an increased roughness and height of erythrocyte membrane. Meanwhile, primaquine induces damages to erythrocytes which could be prevented by vitamin C treatment in normal RBCs but not in G6PD deficient erythrocytes. CONCLUSIONS: Our research may give valuable information about the status of G6PD deficient patients and explore the mechanism of hemolytic anemia.


Cell Membrane Structures/ultrastructure , Erythrocyte Membrane/ultrastructure , Glucosephosphate Dehydrogenase Deficiency/blood , Ascorbic Acid/pharmacology , Cell Membrane Structures/drug effects , Cell Membrane Structures/pathology , Dose-Response Relationship, Drug , Erythrocyte Membrane/drug effects , Erythrocyte Membrane/pathology , Genotype , Glucosephosphate Dehydrogenase Deficiency/pathology , Humans , Microscopy, Atomic Force , Primaquine/pharmacology , Structure-Activity Relationship
11.
Int J Mol Sci ; 16(1): 2252-68, 2015 Jan 20.
Article En | MEDLINE | ID: mdl-25608657

TIPP is a novel thymic immunosuppressive pentapeptide originally obtained from calf thymic immunosuppressive extract. The present study aimed to investigate the inhibitory activity of TIPP on IgE-mediated activation of RBL-2H3 cells. Release of ß-hexosaminidase and histamine, intracellular calcium, membrane ruffling, mRNA levels of cytokines, cyclooxygenase-2 (COX-2) expression, and activation of mitogen-activated protein kinases (MAP kinases) and NF-κB were determined by colorimetric assay, fluorescence spectrophotometer, confocal fluorescence microscope, quantification PCR, and Western blot, respectively. The results showed that TIPP significantly inhibited the degranulation in IgE-antigen complex-stimulated RBL-2H3 cells without cytotoxicity. TIPP significantly suppressed the increase of intracellular calcium and the rearrangement of F-actin, attenuated the transcription of pro-inflammatory cytokines (IL-3, -4, -6, -13, TNF-α, and monocyte chemotactic protein-1 (MCP-1)), and decreased the expression of COX-2. Western blot analysis showed that TIPP had an inhibitory activity on the phosphorylation of extracellular signal-regulated protein kinase 1/2 (ERK1/2) and ERK kinase 1/2 (MEK1/2), and inhibited the activation of NF-κB. The data suggested that TIPP effectively suppressed IgE-mediated activation of RBL-2H3 cells via blocking MEK/ERK and NF-κB signaling pathways.


Immunoglobulin E/metabolism , Immunosuppressive Agents/pharmacology , Mast Cells/metabolism , Oligopeptides/pharmacology , Tetrahydroisoquinolines/pharmacology , Thymus Gland/immunology , Animals , Antigen-Antibody Complex/metabolism , Calcium/metabolism , Cell Death/drug effects , Cell Degranulation/drug effects , Cell Line , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Cyclooxygenase 2/metabolism , Cytokines/genetics , Cytokines/metabolism , Enzyme Activation/drug effects , Histamine/metabolism , Inflammation Mediators/metabolism , Mast Cells/drug effects , Mast Cells/physiology , Mitogen-Activated Protein Kinases/metabolism , NF-kappa B/metabolism , Oligopeptides/chemistry , Protein Transport/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Tetrahydroisoquinolines/chemistry , Thymus Gland/drug effects , beta-N-Acetylhexosaminidases/metabolism
12.
Biochem Biophys Res Commun ; 456(4): 884-90, 2015 Jan 24.
Article En | MEDLINE | ID: mdl-25529450

The 15-kDa selenoprotein (Sep15) has been implicated in etiology of some types of cancer. Herein, inducible RNAi cell lines were established and cell morphology and motility were analyzed. The majority of Sep15-deficient cells (>95%) formed membrane blebs in a dynamic manner. Blebbing cells transformed cell morphology from a normal flat spindle shape to a spherical morphology. In blebbing cells, actin fibers moved to the cell periphery, covering and obscuring visualization of α-tubulin. Bleb formation was suppressed by the inhibitors of Rho-associated protein kinase (ROCK), RhoA or myosin light chain (MLC), restoring blebbing cells to wild-type morphology. RhoA activation and phosphorylation of myosin phosphatase target subunit 1 was induced by Sep15 knockdown. Sep15-deficient cells were non-apoptotic, and displayed a distinct relative localization of F-actin and α-tubulin from typical apoptotic blebbing cells. Our data suggest that Sep15 in Chang liver cells regulates the pathway that antagonizes RhoA/ROCK/MLC-dependent non-apoptotic bleb formation.


Apoptosis , Cell Membrane Structures/metabolism , Cytoskeleton/metabolism , Selenoproteins/deficiency , Signal Transduction , rho-Associated Kinases/metabolism , rhoA GTP-Binding Protein/metabolism , Amides/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Membrane Structures/drug effects , Cytoskeleton/drug effects , Gene Knockdown Techniques , Humans , Myosin-Light-Chain Kinase/antagonists & inhibitors , Pyridines/pharmacology , Selenoproteins/metabolism , Signal Transduction/drug effects
13.
Cell Death Dis ; 5: e1500, 2014 Oct 30.
Article En | MEDLINE | ID: mdl-25356869

The eukaryotic initiation factor eIF4E is essential for cap-dependent initiation of translation in eukaryotes. Abnormal regulation of eIF4E has been implicated in oncogenic transformation. We developed an eIF4E-binding peptide derived from Angel1, a partner of eIF4E that we recently identified. We show here that this peptide fused to a penetratin motif causes drastic and rapid cell death in several epithelial cancer cell lines. This necrotic cell death was characterized by a drop in ATP levels with F-actin network injury being a key step in extensive plasma membrane blebbing and membrane permeabilization. This synthetic eIF4E-binding peptide provides a candidate pharmacophore for a promising new cancer therapy strategy.


Eukaryotic Initiation Factor-4E/metabolism , Neoplasms/pathology , Peptides/pharmacology , Actins/metabolism , Animals , Cell Death/drug effects , Cell Line, Tumor , Cell Membrane Permeability/drug effects , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Humans , Necrosis , Protein Binding/drug effects , Protein Biosynthesis/drug effects , Protein Stability/drug effects , Rabbits
14.
Nat Cell Biol ; 16(10): 931-41, 1-8, 2014 Oct.
Article En | MEDLINE | ID: mdl-25218639

The mechanism by which angiogenic endothelial cells break the physical barrier of the vascular basement membrane and consequently sprout to form new vessels in mature tissues is unclear. Here, we show that the angiogenic endothelium is characterized by the presence of functional podosome rosettes. These extracellular-matrix-degrading and adhesive structures are precursors of de novo branching points and represent a key feature in the formation of new blood vessels. VEGF-A stimulation induces the formation of endothelial podosome rosettes by upregulating integrin α6ß1. In contrast, the binding of α6ß1 integrin to the laminin of the vascular basement membrane impairs the formation of podosome rosettes by restricting α6ß1 integrin to focal adhesions and hampering its translocation to podosomes. Using an ex vivo sprouting angiogenesis assay, transgenic and knockout mouse models and human tumour sample analysis, we provide evidence that endothelial podosome rosettes control blood vessel branching and are critical regulators of pathological angiogenesis.


Cell Membrane Structures/physiology , Endothelial Cells/physiology , Neoplasms/physiopathology , Neovascularization, Pathologic/physiopathology , Animals , Basement Membrane/metabolism , Cell Line, Tumor , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Cells, Cultured , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , HEK293 Cells , HeLa Cells , Humans , Integrin alpha6beta1/genetics , Integrin alpha6beta1/metabolism , Laminin/metabolism , Lung Neoplasms/blood supply , Lung Neoplasms/metabolism , Lung Neoplasms/physiopathology , Male , Matrix Metalloproteinase 14/metabolism , Melanoma, Experimental/blood supply , Melanoma, Experimental/metabolism , Melanoma, Experimental/physiopathology , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Confocal , Microscopy, Fluorescence , Neoplasms/blood supply , Neoplasms/metabolism , Neovascularization, Pathologic/metabolism , RNA Interference , Tetradecanoylphorbol Acetate/pharmacology , Vascular Endothelial Growth Factor A/metabolism , Vascular Endothelial Growth Factor A/pharmacology
15.
J Biol Chem ; 289(37): 25699-710, 2014 Sep 12.
Article En | MEDLINE | ID: mdl-25096578

Cell death by necrosis is emerging not merely as a passive phenomenon but as a cell-regulated process. Here, by using different necrotic triggers, we prove the existence of two distinct necrotic pathways. The mitochondrial reactive oxygen species generator 2,3-dimethoxy-1,4-naphthoquinone elicits necrosis characterized by the involvement of RIP1 and Drp1. However, G5, a non-selective isopeptidase inhibitor, triggers a distinct necrotic pathway that depends on the protein phosphatase PP2A and the actin cytoskeleton. PP2A catalytic subunit is stabilized by G5 treatment, and its activity is increased. Furthermore, PP2Ac accumulates into the cytoplasm during necrosis similarly to HMGB1. We have also defined in the actin-binding protein cofilin-1 a link between PP2A, actin cytoskeleton, and necrotic death. Cofilin-1-severing/depolymerization activity is negatively regulated by phosphorylation of serine 3. PP2A contributes to the dephosphorylation of serine 3 elicited by G5. Finally, a cofilin mutant that mimics phosphorylated Ser-3 can partially rescue necrosis in response to G5.


Actin Cytoskeleton/metabolism , Cofilin 1/metabolism , Nuclear Pore Complex Proteins/metabolism , Protein Phosphatase 2/metabolism , RNA-Binding Proteins/metabolism , Actin Cytoskeleton/ultrastructure , Actin Depolymerizing Factors/chemistry , Cell Membrane Structures/chemistry , Cell Membrane Structures/drug effects , Cofilin 1/chemistry , HT29 Cells , Humans , Mitochondria/drug effects , Mitochondria/metabolism , Necrosis/genetics , Necrosis/metabolism , Nuclear Pore Complex Proteins/chemistry , Protein Phosphatase 2/antagonists & inhibitors , Protein Phosphatase 2/genetics , Proteolysis , Pyrans/pharmacology , RNA-Binding Proteins/chemistry , Reactive Oxygen Species/metabolism , Sulfhydryl Compounds/pharmacology
16.
Protoplasma ; 251(6): 1521-5, 2014 Nov.
Article En | MEDLINE | ID: mdl-24802108

Essential trace elements Ni(2+) and Cu(2+) can block pollen germination without causing cell death. Mechanisms of this effect remain unclear. Using TEM, we studied the effects of Ni(2+) or Cu(2+) treatment on the ultrastructure of the aperture regions in tobacco pollen preparing to germinate in vitro, since in these zones, the main fluxes of water, ions, and metabolites cross the plasmalemma. Neither Ni(2+) nor Cu(2+) altered the cytoplasm ultrastructure, but both affected the reorganization of apertural periplasm during pollen activation. Numerous multilamellar membranous structures continuous with the plasma membrane could be seen in hydrated but not yet activated pollen. When the normal activation was completed, the structures disappeared and the plasmalemma became smooth. In the presence of 1 mM Ni(2+) or 100 µM Cu(2+), these structures preserved its original appearance. It is assumed to be the storage form for the membrane material, which is to provide an initial phase of the pollen tube growth. Ni(2+) and Cu(2+) affect the utilization of these membranes, thereby, blocking the pollen germination.


Cell Membrane Structures/ultrastructure , Copper/toxicity , Nickel/toxicity , Nicotiana/ultrastructure , Periplasm/ultrastructure , Pollen/ultrastructure , Cell Membrane Structures/drug effects , Pollen/drug effects
17.
EMBO Rep ; 14(8): 726-32, 2013 Aug.
Article En | MEDLINE | ID: mdl-23817552

The A3-adenosine receptor (A3AR) has recently emerged as a key regulator of neutrophil behaviour. Using a fluorescent A3AR ligand, we show that A3ARs aggregate in highly polarized immunomodulatory microdomains on human neutrophil membranes. In addition to regulating chemotaxis, A3ARs promote the formation of filipodia-like projections (cytonemes) that can extend up to 100 µm to tether and 'reel in' pathogens. Exposure to bacteria or an A3AR agonist stimulates the formation of these projections and bacterial phagocytosis, whereas an A3AR-selective antagonist inhibits cytoneme formation. Our results shed new light on the behaviour of neutrophils and identify the A3AR as a potential target for modulating their function.


Cell Membrane Structures/ultrastructure , Neutrophils/ultrastructure , Receptor, Adenosine A3/metabolism , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Cell Membrane Structures/microbiology , Escherichia coli/drug effects , Escherichia coli/physiology , HL-60 Cells , Host-Pathogen Interactions , Humans , Ligands , Neutrophils/drug effects , Neutrophils/metabolism , Neutrophils/microbiology , Phagocytosis/drug effects , Protein Binding , Purinergic P1 Receptor Antagonists/pharmacology
18.
Mol Cell Biochem ; 376(1-2): 151-61, 2013 Apr.
Article En | MEDLINE | ID: mdl-23378048

CI-976 is a lysophospholipid acyltransferase antagonist that is known to affect secretory and endocytic membrane-trafficking pathways likely by increasing the lysophospholipid content in membranes. Our previous study suggested that lysophospholipids formed through the action of an intracellular phospholipase A(1), KIAA0725p (also known as DDHD2 and iPLA(1)γ), may be important for the association of this enzyme with membranes. In this study, we examined the effect of CI-976 on the membrane association of KIAA0725p. While in HeLa cells KIAA0725p is localized in the Golgi and cytosol, in mouse embryonic fibroblasts (MEFs), it was found to be principally localized in the cytosol with some on post-endoplasmic reticulum compartments including the cis-Golgi. Treatment of MEFs with CI-976 induced the redistribution of KIAA0725p to membrane tubules, which were in vicinity to fragmented mitochondria. These tubules were not decorated with canonical organelle markers including Golgi proteins. A human KIAA0725p mutant, which exhibits decreased membrane-binding ability, was also redistributed to membrane structures upon CI-976 treatment. Our data suggest that the association of KIAA0725p with membranes is regulated by lipid metabolism, and that CI-976 may create unique membrane structures that can be marked by KIAA0725p.


Anilides/pharmacology , Cell Membrane/drug effects , Enzyme Inhibitors/pharmacology , Phospholipases/metabolism , Sterol O-Acyltransferase/antagonists & inhibitors , Animals , Cell Membrane/metabolism , Cell Membrane/ultrastructure , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Cell Membrane Structures/ultrastructure , Cytosol/drug effects , Cytosol/metabolism , Dynactin Complex , Dyneins/metabolism , Fibroblasts/drug effects , Fibroblasts/metabolism , Golgi Apparatus/drug effects , Golgi Apparatus/metabolism , HeLa Cells/drug effects , Humans , Hydroxysteroid Dehydrogenases/metabolism , Intracellular Membranes/enzymology , Mice , Microtubule-Associated Proteins/metabolism , Mutation , Phospholipases/genetics , Phospholipases A1/metabolism
19.
Micron ; 44: 218-27, 2013 Jan.
Article En | MEDLINE | ID: mdl-22854216

Atomic force microscopy (AFM) allows a researcher to obtain images of red blood cells (RBC) and their membranes. Various effects on blood lead to surface alterations of cell membranes. Such alterations are estimated by a corrugation of membrane surface. This problem is complicated for statistical analysis because the membrane is the ensemble of structures with different sizes. In the present work we used the space Fourier transform to decompose the complex AFM image of the surface into three simpler ones. The parameters of spectral windows were selected according to the natural structures of RBC membranes. This method allowed us to obtain high resolution images for the corresponding spectral windows, to establish specificity of alterations from each effect, to estimate quantitatively the membrane nanostructures at different space scales and to compare their sizes statistically after actions of different agents. The blood intoxication was modeled by adding hemin, furosemide, chlorpromazine and zinc ions into blood, in vitro.


Cell Membrane Structures/drug effects , Cell Membrane Structures/ultrastructure , Cell Membrane/drug effects , Cell Membrane/ultrastructure , Erythrocytes/ultrastructure , Adult , Chlorpromazine/pharmacology , Erythrocytes/cytology , Fourier Analysis , Furosemide/pharmacology , Hemin/pharmacology , Humans , Microscopy, Atomic Force , Nanostructures , Zinc/pharmacology
20.
PLoS One ; 7(9): e46134, 2012.
Article En | MEDLINE | ID: mdl-23029409

Fenestrations are transcellular pores in endothelial cells that facilitate transfer of substrates between blood and the extravascular compartment. In order to understand the regulation and formation of fenestrations, the relationship between membrane rafts and fenestrations was investigated in liver sinusoidal endothelial cells where fenestrations are grouped into sieve plates. Three dimensional structured illumination microscopy, scanning electron microscopy, internal reflectance fluorescence microscopy and two-photon fluorescence microscopy were used to study liver sinusoidal endothelial cells isolated from mice. There was an inverse distribution between sieve plates and membrane rafts visualized by structured illumination microscopy and the fluorescent raft stain, Bodipy FL C5 ganglioside GM1. 7-ketocholesterol and/or cytochalasin D increased both fenestrations and lipid-disordered membrane, while Triton X-100 decreased both fenestrations and lipid-disordered membrane. The effects of cytochalasin D on fenestrations were abrogated by co-administration of Triton X-100, suggesting that actin disruption increases fenestrations by its effects on membrane rafts. Vascular endothelial growth factor (VEGF) depleted lipid-ordered membrane and increased fenestrations. The results are consistent with a sieve-raft interaction, where fenestrations form in non-raft lipid-disordered regions of endothelial cells once the membrane-stabilizing effects of actin cytoskeleton and membrane rafts are diminished.


Cell Membrane Structures/ultrastructure , Endothelial Cells/ultrastructure , Liver/cytology , Membrane Microdomains/ultrastructure , Actins/metabolism , Actins/ultrastructure , Animals , Cell Membrane Structures/drug effects , Cell Membrane Structures/metabolism , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Ketocholesterols/pharmacology , Liver/drug effects , Liver/embryology , Membrane Microdomains/chemistry , Membrane Microdomains/drug effects , Membrane Microdomains/metabolism , Mice , Mice, Inbred C57BL , Micromanipulation , Octoxynol/pharmacology , Vascular Endothelial Growth Factor A/metabolism
...